COX 2 inhibitor and fulminant hepatic failure

Lancet

Volumn 353, Issue 9146, 1999, Pages 40-41

  McCormick, P A ^a   Kennedy, F ^a   Curry, M ^a   Traynor, O ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; NIMESULIDE; SERTRALINE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; LIVER FAILURE; LOW BACK PAIN; PANIC; PRIORITY JOURNAL;

EID: 0033514051     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)74867-4     Document Type: Article

References (4)

1. 1 Ward A, Brogden RN. Nimesulide: a preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states. Drugs 1988; 36: 732-53.
2. 2 Farrel G. Liver disease produced by non-steroidal anti-inflammatory drugs. In: Farrell G, ed. Drug-induced liver disease. Edinburgh: Churchill Livingstone, 1994: 371-88.
3. 3 Shiff SJ, Rigas B. Nonsteroidal anti-inflammatory drugs and colorectal cancer; evolving concepts for their chemoprotective actions. Gastroenterology 1997; 113: 1992-98.
4. 4 Elder DJE, Paraskeva C. NSAIDs to prevent colorectal cancer: a question of sensitivity. Gastroenterology 1997; 113: 1999-2003.